New and updated respiratory syncytial virus (RSV) resources
Home / News & Opportunities / Latest news / Current post
August 13, 2025
The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.
A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).
- Arexvy® must not be administered to pregnant women.
- Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
- Abrysvo® and Arexvy® must not be administered to infants or children.
- The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.
Updated resources include:
- RSV vaccine and monoclonal antibody poster – to facilitate appropriate choice of product
- RSV provider advice fact sheet
- RSV consumer advice fact sheet
- RSV frequently asked questions fact sheet.
For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing
Latest news
From 28 October 2026, rubella and congenital rubella will change from being ‘routine’ to ‘urgent’ notifiable conditions in Victoria under the Public Health and Wellbeing Regulations 2019.
South Eastern Melbourne Primary Health Network (SEMPHN) is providing advance notice of an upcoming open tender opportunity to establish and deliver two new Medicare Mental Health Centres in Cranbourne and Glen Iris.
Mornington Peninsula-based practice Fernbank has become the first non-traditional general practice in south east Melbourne to achieve accreditation – an important milestone for a two-person practice delivering care entirely within residential aged care homes.
